Global Mobile Cardiac Telemetry Market

Mobile Cardiac Telemetry Market Size, Share, Growth Analysis, By Application(lead based and patch based), By Type(hospitals, cardiac centres and others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2202 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 60 | Figures: 75

Mobile Cardiac Telemetry Market News

  • In May 2022, The mobile cardiac telemetry solution VitalPatch RTM was introduced by VitalConnect. The programmable and adaptable platform of the solution meets a range of requirements for cardiac monitoring.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Mobile Cardiac Telemetry Market size was valued at USD 833.8 million in 2019 and is poised to grow from USD 900 million in 2023 to USD 2300 million by 2031, growing at a CAGR of 12.1% in the forecast period (2024-2031).

The mobile cardiac telemetry system market is highly competitive. To increase market penetration, some of the major industry players are engaging in strategic collaborations, regional expansions, and new product launches. VitalConnect, for example, will launch the VitalPatch RTM mobile cardiac telemetry solution in May 2021. The solution has a versatile and programmable platform that can meet a variety of cardiac monitoring requirements. 'BioTelemetry, Inc.', 'Preventice Solutions', 'iRhythm Technologies Inc.', 'Medicomp Inc.', 'Biotricity Inc.', 'Applied Cardiac Systems Inc.', 'Hill-Rom Holdings Inc.', 'Philips Healthcare', 'Medtronic PLC', 'Zoll Medical Corporation', 'Cardionet Inc.', 'GE Healthcare', 'Welch Allyn Inc.', 'BioTel Heart', 'Infosys Limited', 'Comarch SA', 'Infinium Medical', 'Digi International Inc.', 'Telerhythmics LLC', 'Medic4all Group.'

The increased awareness of emerging patch technology, as well as the introduction of new devices with optimised applications, are driving the growth of the mobile cardiac telemetry systems market.

Because of the technological advantage, demand for mobile cardiac telemetry systems is expected to grow significantly over the forecast period. Mobile cardiac telemetry systems allow patients to move around and provide physicians with real-time data on their patients.

During the forecast period, North America is expected to dominate the mobile cardiac telemetry systems market. In the United States, one person dies from cardiovascular disease every 36 seconds. Every year, approximately 659,000 people die from heart disease, accounting for one in every four deaths in the United States. Because of the increasing geriatric population, rising healthcare expenditure, the presence of major service providers with improved healthcare solutions, and the prevalence of cardiac disorders, North America dominates the mobile cardiac telemetry (MCAT) market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Mobile Cardiac Telemetry Systems Market
Buy Now GET FREE SAMPLE
Telemedicine Technologies Market
Buy Now GET FREE SAMPLE
Telemedicine Market
Buy Now GET FREE SAMPLE
Cardiovascular Information System Market
Buy Now GET FREE SAMPLE
Cardiac Monitoring and Cardiac Rhythm Management Devices Market
Buy Now GET FREE SAMPLE
Cardiac Rhythm Management Devices Market
Buy Now GET FREE SAMPLE
Cardiovascular Devices Market
Buy Now GET FREE SAMPLE
Network Telemetry Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Mobile Cardiac Telemetry Market

Report ID: SQMIG35A2202

$5,300
BUY NOW GET FREE SAMPLE